You are here

earnings

What to expect from the rest of pharma's earnings

BioPharma Dive

Mon, 10/30/17 - 09:52 am

3 Bright Spots in Merck's Q3 Results

Motley Fool

Sun, 10/29/17 - 10:14 am

Merck's cyber-attack shaved $135 million off sales

Marketwatch

Sat, 10/28/17 - 11:09 pm

Mydayis sales shine as Shire still looks to divest neuro

BioPharma Dive

Sat, 10/28/17 - 11:07 pm

Earnings Preview: What To Expect From Pfizer On Tuesday

Forbes

Sat, 10/28/17 - 10:54 am

Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline

Motley Fool

Sat, 10/28/17 - 10:31 am

Vertex Pharmaceuticals

Under breakup pressure, Shire cheers grumpy investors with Q3 earnings beat

Fierce Pharma

Fri, 10/27/17 - 02:45 pm

There's a Lot to Like in AbbVie's Q3 Update

Motley Fool

Fri, 10/27/17 - 02:44 pm

Merck raises full-year guidance despite mixed Q3

Drug Delivery Business News

Fri, 10/27/17 - 11:15 am

3 Key Things to Watch in Pfizer's Q3 Results

Motley Fool

Fri, 10/27/17 - 11:06 am

AbbVie says Humira sales will balloon to $21 bln in 2020, shares rise

Yahoo/Reuters

Fri, 10/27/17 - 11:05 am

Gilead warns hep C sales could fall further

BioPharma Dive

Fri, 10/27/17 - 11:01 am

Gilead Sciences

Amgen faces conundrum as biosimilars both help and hurt

BioPharma Dive

Fri, 10/27/17 - 11:00 am

drug manufacturing

Was Celgene’s Third Quarter Really Crash-Worthy?

Motley Fool

Thu, 10/26/17 - 09:37 pm

Boston Scientific meets The Street with Q3 earnings, tops sales forecast

Mass Device

Thu, 10/26/17 - 09:32 pm

Boston Scientific

Stryker posts Q3 beat

Mass Device

Thu, 10/26/17 - 09:30 pm

Bristol-Myers misses 3Q profit forecasts

Yahoo/AP

Thu, 10/26/17 - 11:19 am

Bristol-Myers Squibb

Bard posts Q3 earnings that beat on EPS, miss on sales

Mass Device

Thu, 10/26/17 - 09:23 am

What's Behind Amgen's Q3 Revenue Decline

Motley Fool

Thu, 10/26/17 - 09:22 am

With Advair copies looming, GSK keeps focus on new drugs

Biopharma Dive

Wed, 10/25/17 - 10:12 pm

Trelegy Ellipta

Pages